DEBORAH L. MULLEN

816 total citations
15 papers, 687 citations indexed

About

DEBORAH L. MULLEN is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, DEBORAH L. MULLEN has authored 15 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in DEBORAH L. MULLEN's work include Carbohydrate Chemistry and Synthesis (9 papers), Microbial Natural Products and Biosynthesis (8 papers) and Probiotics and Fermented Foods (6 papers). DEBORAH L. MULLEN is often cited by papers focused on Carbohydrate Chemistry and Synthesis (9 papers), Microbial Natural Products and Biosynthesis (8 papers) and Probiotics and Fermented Foods (6 papers). DEBORAH L. MULLEN collaborates with scholars based in United States and United Kingdom. DEBORAH L. MULLEN's co-authors include Thalia I. Nicas, Nancy Snyder, John K. Young, R. C. Thompson, Lewis Landsberg, Mark J. Zweifel, Stephen C. Wilkie, R. D. G. Cooper, David A. Preston and J E Flokowitsch and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

DEBORAH L. MULLEN

15 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DEBORAH L. MULLEN United States 11 280 240 212 181 110 15 687
Ray Chang United States 11 375 1.3× 208 0.9× 172 0.8× 110 0.6× 87 0.8× 13 811
Robert Cass United States 7 207 0.7× 241 1.0× 195 0.9× 50 0.3× 144 1.3× 10 648
Hidehito Matsui Japan 16 253 0.9× 166 0.7× 143 0.7× 78 0.4× 107 1.0× 71 807
Marina Y. Fosso United States 16 347 1.2× 169 0.7× 143 0.7× 227 1.3× 87 0.8× 24 791
William J. Novick United States 13 144 0.5× 145 0.6× 175 0.8× 54 0.3× 187 1.7× 23 708
Karen Methling Germany 18 382 1.4× 153 0.6× 87 0.4× 120 0.7× 32 0.3× 48 803
Jonathan Cechetto South Korea 16 536 1.9× 198 0.8× 62 0.3× 202 1.1× 38 0.3× 25 1.1k
Charlotte K. Colenso United Kingdom 12 423 1.5× 136 0.6× 186 0.9× 61 0.3× 477 4.3× 17 1.0k
S. Sugawara Japan 15 237 0.8× 43 0.2× 238 1.1× 197 1.1× 192 1.7× 64 733
David A Yurek United States 12 201 0.7× 71 0.3× 99 0.5× 73 0.4× 44 0.4× 23 448

Countries citing papers authored by DEBORAH L. MULLEN

Since Specialization
Citations

This map shows the geographic impact of DEBORAH L. MULLEN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DEBORAH L. MULLEN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DEBORAH L. MULLEN more than expected).

Fields of papers citing papers by DEBORAH L. MULLEN

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DEBORAH L. MULLEN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DEBORAH L. MULLEN. The network helps show where DEBORAH L. MULLEN may publish in the future.

Co-authorship network of co-authors of DEBORAH L. MULLEN

This figure shows the co-authorship network connecting the top 25 collaborators of DEBORAH L. MULLEN. A scholar is included among the top collaborators of DEBORAH L. MULLEN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DEBORAH L. MULLEN. DEBORAH L. MULLEN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kulanthaivel, Palaniappan, Mark A. Strege, Tim A. Smitka, et al.. (2004). Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I. Journal of Biological Chemistry. 279(35). 36250–36258. 83 indexed citations
2.
Zweifel, Mark J., Nancy Snyder, R. D. G. Cooper, et al.. (2003). Glycopeptide Carboxamides Active against Vancomycin-resistant Enterococci.. The Journal of Antibiotics. 56(3). 289–295. 5 indexed citations
3.
Hoskins, JoAnn, Patti Matsushima, DEBORAH L. MULLEN, et al.. (1999). Gene Disruption Studies of Penicillin-Binding Proteins 1a, 1b, and 2a in Streptococcus pneumoniae. Journal of Bacteriology. 181(20). 6552–6555. 62 indexed citations
4.
Snyder, Nancy, R. D. G. Cooper, Milton J. Zmijewski, et al.. (1998). Enzymatic Deacylation of Teicoplanin Followed by Reductive Alkylation: Synthesis and Antibacterial Activity of New Glycopeptides.. The Journal of Antibiotics. 51(10). 945–951. 15 indexed citations
5.
Rodriguez, Michael, Nancy Snyder, Mark J. Zweifel, et al.. (1998). Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci.. The Journal of Antibiotics. 51(6). 560–569. 45 indexed citations
6.
Nicas, Thalia I., et al.. (1997). Tripeptide LY301621 and Its Diastereomers as Methicillin Potentiators against Methicillin Resistant Staphylococcus aureus.. The Journal of Antibiotics. 50(3). 283–285. 10 indexed citations
7.
Nicas, Thalia I., et al.. (1997). Design, syntheses and potentiating activities against methicillin resistant Staphylococcus aureus of cyclic analogs of LY301621. Bioorganic & Medicinal Chemistry Letters. 7(16). 2087–2092. 5 indexed citations
8.
Nicas, Thalia I., DEBORAH L. MULLEN, J E Flokowitsch, et al.. (1996). Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.. The Journal of Antibiotics. 40. 2194–2199. 18 indexed citations
9.
Cooper, R. D. G., Nancy Snyder, Mark J. Zweifel, et al.. (1996). Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.. The Journal of Antibiotics. 49(6). 575–581. 151 indexed citations
10.
Nicas, Thalia I., DEBORAH L. MULLEN, J E Flokowitsch, et al.. (1996). Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy. 40(9). 2194–2199. 96 indexed citations
11.
Wilkie, Stephen C., Nancy Snyder, Mark J. Zweifel, et al.. (1995). New semisynthetic glycopeptide antibiotics Structure-activity relationship of the N-alkylated disaccharide. 35. 156. 1 indexed citations
12.
Nicas, Thalia I., DEBORAH L. MULLEN, J E Flokowitsch, et al.. (1995). Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrobial Agents and Chemotherapy. 39(11). 2585–2587. 45 indexed citations
13.
Ünal, Serhat, J E Flokowitsch, DEBORAH L. MULLEN, David A. Preston, & Thalia I. Nicas. (1993). In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates. Journal of Antimicrobial Chemotherapy. 31(5). 711–723. 15 indexed citations
14.
Flaugh, Michael E., DEBORAH L. MULLEN, Ray W. Fuller, & Norman R. Mason. (1988). 6-Substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists. Journal of Medicinal Chemistry. 31(9). 1746–1753. 31 indexed citations
15.
Young, John K., DEBORAH L. MULLEN, & Lewis Landsberg. (1978). Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism. 27(12). 1711–1714. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026